Tesla’s stock performance is tied closely to its Model 3 production, and Goldman claims the company’s production goals are unfeasible.
“We believe the sustainable production rate for the second quarter of 2018 is most likely below the 2,000 vehicle mark the company achieved in the final week of the [first] quarter,” Goldman analyst David Tamberrino wrote, according to CNBC. “We see the company likely sustaining Model 3 production around the 1,400 per week mark.”
Mr. Musk’s response to the analysis was brief.
“Place your bets…” Mr. Musk tweeted.
More articles on business:
Boeing swipes $12B American Airlines order from rival Airbus
Viacom asks CBS to increase merger offer by $2.8B
Facebook suspends 2 more analytics companies in wake of scandal
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
